Emulating on the successful Viral Vector Process Development Summit in Boston, we are excited to connect thought leaders in CMC, Regulatory, Upstream and Downstream Processing in Europe this summer – addressing the unique challenges in this emerging market.

The Viral Vector Formulation & Process Development Summit Europe is the meeting approaching the most prominent challenges in the context of viral vector-based vaccine, gene and cell therapy process development in Europe.

Across 2 days, this summit will help you to benchmark your formulation, process development and understand reference materials against the most common vector candidates, navigate through the fast-evolving regulatory landscape and achieve a seamless scale-up.

Hear first-hand experience from the likes of Roche, VectorY, UCB, Boehringer Ingelheim and AviadoBio and many more to avoid common pitfalls:

• 2 main conference days packed with 14+ case studies with technical updates and 3 roundtable discussions to spark innovations and conversation
• 3 and a half hours of networking opportunities to interact with industry thought leaders and build meaningful relationships

This is a unique forum dedicated to viral vector process development professionals in Europe so clear 2 days of your agenda and be part of the conversation in July.